After Bosco Pharmaceutical's acquisition of Zeta AG, the Bosco chairman is unsure whether to unify both firms using internal resources or accept the help of Deloitte Consulting. Deloitte recommend an overhaul of Bosco's organizational structure to accommodate Zeta, a firm one fifth Bosco's size.
The chairman is unsure whether Zeta should be required to conform to Bosco's more geographic management and operating structure or whether to adopt the worldwide product structure of Zeta. This merger would be the largest in Bosco's 110-year history, and it is critical to extract benefits from it-mostly by meshing the corporate cultures and achieving challenging cost savings.
PUBLICATION DATE: November 13, 2008 PRODUCT #: UV1015-HCB-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
iPhone Applications: Viable Business or Time-Consuming Hobby
Customer Discovery and Validation for Entrepreneurs
The Change Wheel: Elements of Systemic Change and How to Get Change Rolling
Sheila Mason & Craig Shepherd (Abridged)
The High Stakes of Low-Cost Competition
Pushing the Envelope: Engine Development and Procurement for the F-15 Fighter Jet (A)
Module III–Moral Leadership Class Summaries
Problems with Probabilities
VICTORIA HEAVY EQUIPMENT COMPANY
Accounting for pension and Employee benefit at Ford and Toyota:
